- Description
- Benefits
- Risks
- Additional information
- Research
Description
Follistatin 344 (FST-344) is a recombinant protein peptide studied in laboratory environments for its role in myostatin binding, muscle growth regulation, and cellular signalling pathways. It is a naturally occurring glycoprotein that interacts with members of the TGF-beta superfamily, particularly myostatin (GDF-8) and activins.
In controlled research settings, Follistatin 344 is investigated for its ability to bind and inhibit myostatin, a protein that limits muscle development. This has made it a key compound in studies related to muscle hypertrophy, tissue growth regulation, and protein signalling.
As interest in pure peptides across Ireland and Europe continues to expand, Follistatin 344 is commonly used in research focusing on:
- Myostatin inhibition and muscle growth pathways
- Activin binding and TGF-beta signalling
- Cellular growth regulation and protein expression
- Tissue development and regenerative biology models
This product is supplied as a high-purity research peptide, intended strictly for scientific and laboratory use.
Disclaimer: This product is strictly for research purposes only and is not for human consumption.
Technical Information – Follistatin 344
| Specification | Details |
|---|---|
| Product Name | Follistatin 344 (FST-344) |
| Compound Type | Recombinant protein |
| Functional Class | Myostatin and activin-binding protein |
| Mechanism of Action | Binds and inhibits myostatin and activins |
| Biological Targets | Myostatin (GDF-8), activins, TGF-beta pathways |
| Molecular Structure | Glycoprotein (follistatin isoform 344) |
| Format | Lyophilised powder |
| Purity | Research-grade |
| Storage | Refrigerated (2–8°C, protected from light) |
| Application | Laboratory research use only |
* Images for illustration purposes only
Further Refrences: PubChem Entry
Researched Benefits & Focus Areas – Follistatin 344
1. Myostatin Inhibition Research
Follistatin 344 has been studied for:
- Binding and neutralising myostatin (GDF-8)
- Reducing inhibitory signals on muscle growth pathways
- Supporting research into muscle hypertrophy mechanisms
Reference basis: Derived from molecular biology and endocrinology research examining myostatin inhibition and follistatin protein interactions.
2. Activin Binding & TGF-Beta Modulation
Research has explored its role in:
- Binding to activins and related growth factors
- Modulating TGF-beta signalling pathways
- Influencing cellular growth regulation systems
Reference basis: Based on biochemical studies investigating follistatin’s interaction with activins and the TGF-beta superfamily.
3. Muscle Growth & Tissue Development Models
Follistatin 344 is commonly studied in:
- Muscle development and regeneration models
- Protein synthesis and anabolic signalling research
- Tissue growth and structural adaptation studies
Reference basis: Supported by preclinical research examining muscle growth regulation and follistatin’s role in protein expression pathways.
4. Cellular Signalling & Protein Expression
- Investigated for its influence on gene expression pathways
- Explored in cellular differentiation and growth models
- Role in regulating biological signalling cascades
Reference basis: Derived from cell biology and protein signalling research involving follistatin-mediated regulation.
⚠️ Disclaimer: These are research-based findings only. This product is not intended for human use or consumption.
Researched Risks & Considerations – Follistatin 344
1. Broad Growth Factor Interaction
Due to its binding profile:
- May influence multiple signalling pathways beyond myostatin
- Potential for non-specific biological effects
Reference basis: Based on research into follistatin’s interaction with activins and TGF-beta family proteins.
2. Regulation Imbalance in Growth Pathways
- Inhibition of myostatin may lead to disruption of natural growth control
- Potential for unregulated tissue signalling in models
Reference basis: Derived from endocrinology studies on myostatin’s role in maintaining muscle homeostasis.
3. Limited Human Data
- Research is largely preclinical
- Lack of extensive human trials
- Long-term effects remain uncertain
Reference basis: Reflects the current stage of follistatin-based research compounds.
4. Systemic Biological Impact
- May affect multiple tissues due to widespread receptor interaction
- Requires controlled laboratory analysis
Reference basis: Based on studies examining systemic effects of growth factor modulation.
Disclaimer: These risks are based on available research data only. This product is strictly a research peptide and not for human consumption.
Additional information
| Weight | 23 kg |
|---|---|
| Dimensions | 12 × 23 × 56 cm |
| Quantity | 1 Vial, 1 Kit (10 Vials) |
Related Products
FEATURED PRODUCTS
BEST SELLING PRODUCTS
LATEST PRODUCTS
TOP RATED PRODUCTS